Dexcom Inc: BTIG raises target price to $96 from $90
DXCM•BTIG raised its target price for Dexcom Inc to $96 from $90.
Related News
Biogen, Datadog, Tesla among companies with revised analyst ratings and targets
BIIB•
US lithium-ion battery maker Enovix's Q3 preliminary revenue beats estimates, helped by defense demand
ENVX•
AgEagle names Ivan Stamatovski chief technology officer in new C-suite role
UAVS•
IDEXX Laboratories: KeyBanc initiates coverage with Sector Weight rating
IDXX•
Meritage Homes Corp: Goldman Sachs cuts target price to $82 from $93
MTH•